Table 2.
Effect of antcin C on hepatic enzyme leakage, lipid peroxidation and glutathione depletion in AAPH-challenged mouse serum or liver tissues.
| Parameters | AAPH (80 mg/Kg b.w) | |||||
|---|---|---|---|---|---|---|
| Antcin (mg/Kg b.w) | Silymarin (mg/Kg b.w) | |||||
| Control | 25 | 50 | 100 | 200 | ||
| Serum ALT (U/L) | 4.1 ± 0.2 | 6.2 ± 2.3† | 4.9 ± 1.4** | 4.6 ± 0.1*** | 4.2 ± 0.1*** | 4.4 ± 0.2*** |
| Serum AST (U/L) | 3.7 ± 0.2 | 4.2 ± 0.5† | 4.1 ± 0.7* | 3.7 ± 0.2*** | 3.4 ± 0.2*** | 3.6 ± 0.1*** |
| Hepatic GSH (mM) | 97.2 ± 2.7 | 54.3 ± 9.9† | 90.9 ± 7.9** | 125.6 ± 8.4*** | 162.3 ± 18.8*** | 216.5 ± 38.2*** |
| Serum GSH (mM) | 7.5 ± 2.6 | 7.9 ± 7.3 | 21.1 ± 7.2** | 49.9 ± 8.0*** | 92.6 ± 2.1*** | 81.9 ± 1.5*** |
| Hepatic MDA (mM) | 6.2 ± 1.1 | 20.9 ± 1.2† | 13.3 ± 1.1* | 10.7 ± 1.2** | 6.4 ± 1.2*** | 6.6 ± 1.3*** |
Values represent the mean ± SD of three independent experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 were considered significant for sample versus. AAPH. † P < 0.05 was considered significant for control versus AAPH.